SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales is pegged at Rs. 390.60 millions for the March 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 413.98 millions during the year-ago period.A slender decline of -9.89% was recorded to Rs. 13.12  millions from Rs. 14.56 millions in the corresponding previous quarter.Operating Profit saw a handsome growth to 41.38 millions from 34.03 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 390.60 413.98 -5.65 1458.57 1524.66 -4.33 1458.57 1524.66 -4.33
Other Income 10.25 5.15 99.03 27.42 35.22 -22.15 27.42 35.22 -22.15
PBIDT 41.38 34.03 21.60 139.19 146.34 -4.89 139.19 146.34 -4.89
Interest 8.22 6.76 21.60 27.31 22.90 19.26 27.31 22.90 19.26
PBDT 15.27 27.27 -44.00 90.42 123.44 -26.75 90.42 123.44 -26.75
Depreciation 2.15 12.71 -83.08 48.90 49.95 -2.10 48.90 49.95 -2.10
PBT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 10.59 8.22 28.88 9.54 9.60 -0.58 9.54 9.60 -0.58

Bafna Pharma Share Price

135.00 -7.10 (-5.00%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×